387 related articles for article (PubMed ID: 24016813)
1. Preparation and immunoprotection of subgroup B avian leukosis virus inactivated vaccine.
Li X; Dong X; Sun X; Li W; Zhao P; Cui Z; Wang X
Vaccine; 2013 Nov; 31(46):5479-85. PubMed ID: 24016813
[TBL] [Abstract][Full Text] [Related]
2. Antibody responses induced by recombinant ALV-A gp85 protein vaccine combining with CpG-ODN adjuvant in breeder hens and the protection for their offspring against early infection.
Zhang D; Li H; Zhang Z; Sun S; Cheng Z; Liu J; Zhao P; Ren Q; Guo H
Antiviral Res; 2015 Apr; 116():20-6. PubMed ID: 25637708
[TBL] [Abstract][Full Text] [Related]
3. Maternal antibody induced by recombinant gp85 protein vaccine adjuvanted with CpG-ODN protects against ALV-J early infection in chickens.
Dou W; Li H; Cheng Z; Zhao P; Liu J; Cui Z; Liu H; Jing W; Guo H
Vaccine; 2013 Dec; 31(51):6144-9. PubMed ID: 23831319
[TBL] [Abstract][Full Text] [Related]
4. Preparation of the Secretory Recombinant ALV-J gp85 Protein Using Pichia pastoris and Its Immunoprotection as Vaccine Antigen Combining with CpG-ODN Adjuvant.
Jing W; Zhou J; Wang C; Qiu J; Guo H; Li H
Viral Immunol; 2018; 31(6):407-416. PubMed ID: 29698128
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Marek's Disease Virus as a Vector-Based Vaccine against Avian Leukosis Virus Subgroup J in Chicken.
Liu Y; Li K; Gao Y; Gao L; Zhong L; Zhang Y; Liu C; Zhang Y; Wang X
Viruses; 2016 Nov; 8(11):. PubMed ID: 27827933
[TBL] [Abstract][Full Text] [Related]
6. Liposomes containing recombinant gp85 protein vaccine against ALV-J in chickens.
Zhang L; Cai D; Zhao X; Cheng Z; Guo H; Qi C; Liu J; Xu R; Zhao P; Cui Z
Vaccine; 2014 May; 32(21):2452-6. PubMed ID: 24625339
[TBL] [Abstract][Full Text] [Related]
7. Avian leukosis virus (ALV) infection, shedding, and tumors in maternal ALV antibody-positive and -negative chickens exposed to virus at hatching.
Fadly AM
Avian Dis; 1988; 32(1):89-95. PubMed ID: 2838017
[TBL] [Abstract][Full Text] [Related]
8. Effects of chemically or virus-induced immunodepression on response of chickens to avian leukosis virus.
Fadly AM; Witter RL; Lee LF
Avian Dis; 1985; 29(1):12-25. PubMed ID: 2985037
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of an autophagy-targeted DNA vaccine against avian leukosis virus subgroup J.
Dai Z; Huang J; Lei X; Yan Y; Lu P; Zhang H; Lin W; Chen W; Ma J; Xie Q
Vaccine; 2017 Feb; 35(5):808-813. PubMed ID: 28049588
[TBL] [Abstract][Full Text] [Related]
10. A novel multi-variant epitope ensemble vaccine against avian leukosis virus subgroup J.
Wang X; Zhou D; Wang G; Huang L; Zheng Q; Li C; Cheng Z
Vaccine; 2017 Dec; 35(48 Pt B):6685-6690. PubMed ID: 29054728
[TBL] [Abstract][Full Text] [Related]
11. Influence of maternal antibody on avian leukosis virus infection in White Leghorn chickens harboring endogenous virus-21 (EV21).
Fadly AM; Smith EJ
Avian Dis; 1991; 35(3):443-51. PubMed ID: 1659362
[TBL] [Abstract][Full Text] [Related]
12. Influence of endogenous viral (ev) gene expression and strain of exogenous avian leukosis virus (ALV) on mortality and ALV infection and shedding in chickens.
Crittenden LB; Smith EJ; Fadly AM
Avian Dis; 1984; 28(4):1037-56. PubMed ID: 6098248
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a chimeric multi-epitope-based DNA vaccine against subgroup J avian leukosis virus in chickens.
Xu Q; Cui N; Ma X; Wang F; Li H; Shen Z; Zhao X
Vaccine; 2016 Jul; 34(33):3751-6. PubMed ID: 27318415
[TBL] [Abstract][Full Text] [Related]
14. Isolation and some characteristics of a subgroup J-like avian leukosis virus associated with myeloid leukosis in meat-type chickens in the United States.
Fadly AM; Smith EJ
Avian Dis; 1999; 43(3):391-400. PubMed ID: 10494407
[TBL] [Abstract][Full Text] [Related]
15. gp85 protein vaccine adjuvanted with silica nanoparticles against ALV-J in chickens.
Cheng J; Wen S; Wang S; Hao P; Cheng Z; Liu Y; Zhao P; Liu J
Vaccine; 2017 Jan; 35(2):293-298. PubMed ID: 27912987
[TBL] [Abstract][Full Text] [Related]
16. Novel carbon quantum dots can serve as an excellent adjuvant for the gp85 protein vaccine against avian leukosis virus subgroup J in chickens.
Cheng J; Xu Y; Zhou D; Liu K; Geng N; Lu J; Liu Y; Liu J
Poult Sci; 2019 Nov; 98(11):5315-5320. PubMed ID: 31198967
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of an adventitious avian leukosis virus isolated from commercial Marek's disease vaccines.
Fadly A; Silva R; Hunt H; Pandiri A; Davis C
Avian Dis; 2006 Sep; 50(3):380-5. PubMed ID: 17039837
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of various parental lines of commercial white leghorn layers to infection with a naturally occurring recombinant avian leukosis virus containing subgroup B envelope and subgroup J long terminal repeat.
Mays JK; Pandiri AR; Fadly AM
Avian Dis; 2006 Sep; 50(3):342-7. PubMed ID: 17039832
[TBL] [Abstract][Full Text] [Related]
19. Cooperative effects of immune enhancer TPPPS and different adjuvants on antibody responses induced by recombinant ALV-J gp85 subunit vaccines in SPF chickens.
Li Y; Meng F; Cui S; Fu J; Wang Y; Cui Z; Chang S; Zhao P
Vaccine; 2017 Mar; 35(12):1594-1598. PubMed ID: 28237498
[TBL] [Abstract][Full Text] [Related]
20. Response of white leghorn chickens to infection with avian leukosis virus subgroup J and infectious bursal disease virus.
Williams SM; Sellers HS
Avian Dis; 2012 Mar; 56(1):2-6. PubMed ID: 22545522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
